Pieris Pharmaceuticals, Inc.

  • Home
  • About
  • Pipeline
  • Investors
    • Overview
    • News & Events
    • Publications
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

In December 2024, Pieris Pharmaceuticals merged with Palvella Therapeutics, Inc. Palvella Therapeutics (Nasdaq: PVLA), is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. For more information about the Company and updates, please visit www.palvellatx.com or follow us on LinkedIn.

Continue
Jul 24, 2024 6:30am EDT

Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement

Apr 19, 2024 12:10pm EDT

Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split

Mar 27, 2024 8:00am EDT

Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential

Aug 17, 2023 8:00am EDT

Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific

Jul 18, 2023 9:15am EDT

Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring

Jun 21, 2023 7:00am EDT

Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study

Jun 02, 2023 4:30pm EDT

Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference

May 22, 2023 8:00am EDT

Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference

May 21, 2023 8:00am EDT

Pieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference

May 10, 2023 7:00am EDT

Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …26
  • Next
RSS
© 2025 Pieris Pharmaceuticals, Inc. All Rights Reserved.
Imprint Privacy Policy Disclaimer Sitemap Contact Us Manage Cookie Preferences